Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DOC NYSE:HHH NYSE:OWL NASDAQ:TSHA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCHealthpeak Properties$22.86+1.5%$20.80$15.70▼$22.95$15.76B1.028.72 million shs7.36 million shsHHHHoward Hughes$67.31+2.1%$67.90$61.01▼$91.07$4.01B1.12443,934 shs436,769 shsOWLBlue Owl Capital$9.84+1.6%$9.49$7.95▼$20.58$15.29B1.2226.64 million shs13.92 million shsTSHATaysha Gene Therapies$5.46-1.4%$5.97$2.54▼$7.30$1.57B1.172.89 million shs2.56 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCHealthpeak Properties+1.06%+1.14%+4.73%+40.41%+27.75%HHHHoward Hughes+0.19%-3.66%-8.62%+3.19%-5.35%OWLBlue Owl Capital+2.29%+3.18%+12.79%+9.11%-51.57%TSHATaysha Gene Therapies+0.36%-0.72%-12.62%-12.06%+109.06%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDOCHealthpeak Properties$22.86+1.5%$20.80$15.70▼$22.95$15.76B1.028.72 million shs7.36 million shsHHHHoward Hughes$67.31+2.1%$67.90$61.01▼$91.07$4.01B1.12443,934 shs436,769 shsOWLBlue Owl Capital$9.84+1.6%$9.49$7.95▼$20.58$15.29B1.2226.64 million shs13.92 million shsTSHATaysha Gene Therapies$5.46-1.4%$5.97$2.54▼$7.30$1.57B1.172.89 million shs2.56 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDOCHealthpeak Properties+1.06%+1.14%+4.73%+40.41%+27.75%HHHHoward Hughes+0.19%-3.66%-8.62%+3.19%-5.35%OWLBlue Owl Capital+2.29%+3.18%+12.79%+9.11%-51.57%TSHATaysha Gene Therapies+0.36%-0.72%-12.62%-12.06%+109.06%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDOCHealthpeak Properties 2.21Hold$20.62-9.80% DownsideHHHHoward Hughes 1.33Sell$79.0017.37% UpsideOWLBlue Owl Capital 2.56Moderate Buy$13.1633.83% UpsideTSHATaysha Gene Therapies 3.00Buy$12.77133.87% UpsideCurrent Analyst Ratings BreakdownLatest HHH, TSHA, DOC, and OWL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/21/2026TSHATaysha Gene Therapies The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$11.00 ➝ $13.007/21/2026HHHHoward Hughes Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell7/20/2026OWLBlue Owl Capital Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold7/17/2026HHHHoward Hughes Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)7/17/2026OWLBlue Owl Capital OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$16.00 ➝ $15.007/16/2026HHHHoward Hughes JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$76.00 ➝ $79.007/15/2026DOCHealthpeak Properties Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$20.00 ➝ $22.007/13/2026OWLBlue Owl Capital Capital One FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$11.007/13/2026OWLBlue Owl Capital BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$12.00 ➝ $11.007/9/2026OWLBlue Owl Capital CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Outperform7/9/2026OWLBlue Owl Capital Citizens JmpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Outperform$21.00 ➝ $17.00(Data available from 7/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDOCHealthpeak Properties$2.82B5.58$1.52 per share15.08$11.72 per share1.95HHHHoward Hughes$1.47B2.72$6.34 per share10.62$49.69 per share1.35OWLBlue Owl Capital$2.94B5.20$1.14 per share8.65$3.89 per share2.53TSHATaysha Gene Therapies$7.47M210.01N/AN/A$0.90 per share6.07Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDOCHealthpeak Properties$71.35M$0.3271.4312.913.467.73%2.61%1.09%8/4/2026 (Confirmed)HHHHoward Hughes$131.88M$2.0433.0021.78N/A8.04%5.41%1.61%N/AOWLBlue Owl Capital$78.83M$0.1281.969.931.022.96%21.97%10.79%7/30/2026 (Estimated)TSHATaysha Gene Therapies-$109M-$0.38N/AN/AN/AN/A-56.07%-40.16%8/11/2026 (Estimated)Latest HHH, TSHA, DOC, and OWL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2026Q2 2026TSHATaysha Gene Therapies-$0.11N/AN/AN/A$0.62 millionN/A8/4/2026Q2 2026DOCHealthpeak Properties$0.0282N/AN/AN/A$725.64 millionN/A7/30/2026Q2 2026OWLBlue Owl Capital$0.21N/AN/AN/A$694.65 millionN/A5/7/2026Q1 2026HHHHoward Hughes$0.08$0.14+$0.06$0.14N/A$235.92 million5/6/2026Q1 2026TSHATaysha Gene Therapies-$0.10-$0.12-$0.02-$0.12$0.76 millionN/A5/5/2026Q1 2026DOCHealthpeak Properties$0.43$0.45+$0.02$0.28$694.59 million$752.95 million4/30/2026Q1 2026OWLBlue Owl Capital$0.19$0.19N/A$0.02$687.23 million$699.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthDOCHealthpeak Properties$1.225.34%-3.79%381.25%N/AHHHHoward HughesN/AN/AN/AN/AN/AOWLBlue Owl Capital$0.929.35%N/A766.67%4 YearsTSHATaysha Gene TherapiesN/AN/AN/AN/AN/ALatest HHH, TSHA, DOC, and OWL DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/9/2026DOCHealthpeak Propertiesmonthly$0.10175.65%9/14/20269/14/20269/25/20267/9/2026DOCHealthpeak Propertiesmonthly$0.10175.65%8/17/20268/17/20268/28/20267/9/2026DOCHealthpeak Propertiesmonthly$0.10175.48%7/20/20267/20/20267/31/20264/28/2026OWLBlue Owl Capitalquarterly$0.239.42%5/13/20265/13/20265/27/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDOCHealthpeak Properties1.152.962.96HHHHoward Hughes1.971.581.58OWLBlue Owl CapitalN/AN/AN/ATSHATaysha Gene Therapies0.2314.0414.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDOCHealthpeak Properties93.57%HHHHoward Hughes93.83%OWLBlue Owl Capital35.85%TSHATaysha Gene Therapies77.70%Insider OwnershipCompanyInsider OwnershipDOCHealthpeak Properties0.23%HHHHoward Hughes48.00%OWLBlue Owl Capital25.74%TSHATaysha Gene Therapies3.48%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDOCHealthpeak Properties200689.42 million687.83 millionOptionableHHHHoward Hughes60859.62 million31.01 millionOptionableOWLBlue Owl Capital1,3651.55 billion1.15 billionOptionableTSHATaysha Gene Therapies180287.36 million277.36 millionOptionableHHH, TSHA, DOC, and OWL HeadlinesRecent News About These CompaniesTaysha Gene Therapies, Inc. $TSHA Holdings Trimmed by Healthcare of Ontario Pension Plan Trust FundJuly 28 at 5:19 AM | marketbeat.comTaysha Gene Therapies (NASDAQ:TSHA) Trading 8% Higher - Still a Buy?July 27 at 12:39 PM | marketbeat.comTaysha Gene Therapies, Inc. $TSHA Shares Acquired by Rice Hall James & Associates LLCJuly 26 at 6:23 AM | marketbeat.comTaysha Gene Therapies, Inc. $TSHA Position Reduced by Affinity Asset Advisors LLCJuly 25 at 3:04 AM | marketbeat.comSiren L.L.C. Sells 1,300,000 Shares of Taysha Gene Therapies, Inc. $TSHAJuly 24, 2026 | marketbeat.comTaysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Rating of "Buy" by BrokeragesJuly 24, 2026 | marketbeat.comTaysha Gene Therapies (TSHA) is One of The Most Affordable Biotech Names to Invest InJuly 15, 2026 | finance.yahoo.comTaysha Gene Therapies (NASDAQ:TSHA) Shares Up 7.4% - Still a Buy?July 14, 2026 | marketbeat.comInsider Selling: Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells 200,000 Shares of StockJuly 11, 2026 | insidertrades.comTaysha Gene Therapies (NASDAQ:TSHA) Insider Sells 200,000 Shares of StockJuly 10, 2026 | marketbeat.comTaysha Gene Therapies (NASDAQ:TSHA) Shares Down 7.3% - What's Next?July 10, 2026 | marketbeat.comTaysha: 'Buy' On Interim Analysis Of TSHA-102 First Half 2027 And Broad Label PotentialJune 30, 2026 | seekingalpha.comTaysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsJune 25, 2026 | finanznachrichten.deTaysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical ...June 25, 2026 | enidnews.comETaysha Gene Therapies Announces Major Equity Financing DealJune 25, 2026 | tipranks.comTaysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific MeetingJune 25, 2026 | globenewswire.comTaysha Gene Therapies shares tumble following pricing shares at $6.00 to raise $200MJune 25, 2026 | msn.comTaysha Gene Therapies Prices $200 Million Public Offering of Common Stock and Pre-Funded WarrantsJune 24, 2026 | quiverquant.comQTaysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsJune 24, 2026 | globenewswire.comTaysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsJune 24, 2026 | globenewswire.comAnalysts Offer Insights on Healthcare Companies: Taysha Gene Therapies (TSHA) and AbbVie (ABBV)June 23, 2026 | theglobeandmail.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 20265 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026Rocket Lab’s Stock Drop Comes With a Bullish TwistBy Ryan Hasson | July 10, 2026AirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 2026Catching the AI Wave: DigitalOcean Reels in AI WhalesBy Jeffrey Neal Johnson | July 9, 2026HHH, TSHA, DOC, and OWL Company DescriptionsHealthpeak Properties NYSE:DOC$22.86 +0.34 (+1.50%) Closing price 03:59 PM EasternExtended Trading$22.82 -0.03 (-0.14%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.Howard Hughes NYSE:HHH$67.31 +1.36 (+2.06%) Closing price 03:59 PM EasternExtended Trading$67.10 -0.21 (-0.31%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Howard Hughes Holdings Inc., together with its subsidiaries, operates as a real estate development company in the United States. It operates in four segments: Operating Assets; Master Planned Communities (MPCs); Seaport; and Strategic Developments. The Operating Assets segment consists of developed or acquired retail, office, and multi-family properties along with other retail investments. Its MPCs segment develops, sells, and leases residential and commercial land designated for long-term community development projects in and around Las Vegas, Nevada; Houston, Texas; and Phoenix, Arizona. The Seaport segment is involved in the landlord operations, managed businesses, and events and sponsorships services of its restaurant, retail, and entertain properties in Pier 17, New York City; Historic Area/Uplands; and Tin Building, as well as in 250 Water Street and in the Jean-Georges restaurants. The Strategic Development segment develops and redevelops residential condominiums and commercial properties. It serves homebuilders. Howard Hughes Holdings Inc. was founded in 2010 and is headquartered in The Woodlands, Texas.Blue Owl Capital NYSE:OWL$9.84 +0.16 (+1.60%) Closing price 03:59 PM EasternExtended Trading$9.82 -0.01 (-0.10%) As of 05:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Blue Owl Capital Inc. operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants. It offers its solutions through permanent capital vehicles, as well as long-dated private funds. Blue Owl Capital Inc. is headquartered in New York, New York.Taysha Gene Therapies NASDAQ:TSHA$5.46 -0.08 (-1.44%) Closing price 04:00 PM EasternExtended Trading$5.44 -0.02 (-0.44%) As of 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction Amkor Sells Off After Earnings—Why Weak Guidance Isn't the Real Story Nano Nuclear’s Air Force Contract Puts Its Short-Squeeze Setup in Focus Western Digital’s Earnings Will Test Whether Its AI Rally Has More Room 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys? Is the Market Mispricing ServiceNow's AI Future? Chips & Clips: Memory Tariffs Rewire Tech Supply Chains Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
